C1QTNF2: A Potential Drug Target and Biomarker (G114898)

Target Name: C1QTNF2

NCBI ID: G114898

C1QTNF2

C1QTNF2: A Potential Drug Target and Biomarker

C1QTNF2, also known as C1QTNF2 variant 1, is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The C1QTNF2 gene is a member of the cytomegalovirus (CMV) family, which is known to be involved in the development and progression of a number of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

The C1QTNF2 gene is located on chromosome 6p21 and encodes for a protein known as C1QTNF2. This protein is involved in the regulation of cellular processes that are important for cell survival and growth, including cell adhesion, migration, and invasion. It is also involved in the regulation of inflammation and immune responses.

Studies have identified C1QTNF2 as a potential drug target for a number of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. One of the main reasons for its potential as a drug target is its involvement in the regulation of cellular processes that are important for disease development and progression. For example, studies have shown that C1QTNF2 is involved in the regulation of cell adhesion and migration, which are important processes for the development of cancer. Additionally, C1QTNF2 is involved in the regulation of inflammation and immune responses, which are important processes for the treatment of autoimmune diseases.

Another reason for C1QTNF2's potential as a drug target is its expression in a wide range of tissues and cells, including cancer cells, neurons, and immune cells. This makes it a potential target for drugs that can affect its expression and activity throughout the body. Additionally, C1QTNF2 is a protein that is expressed in most tissues and cells, which makes it a potential biomarker for a wide range of diseases.

In addition to its potential as a drug target and biomarker, C1QTNF2 is also a potential biomarker for a number of diseases. For example, studies have shown that C1QTNF2 is involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Additionally, C1QTNF2 is involved in the regulation of cellular processes that are important for the development and progression of cancer, which makes it a potential biomarker for cancer.

Overall, C1QTNF2 is a gene that has the potential to be a drug target and biomarker for a wide range of diseases. Further research is needed to fully understand its role in disease development and progression.

Protein Name: C1q And TNF Related 2

Functions: Involved in the regulation of lipid metabolism in adipose tissue and liver

The "C1QTNF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1QTNF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets